vs

Side-by-side financial comparison of INDEPENDENT BANK CORP (INDB) and Penumbra Inc (PEN). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $212.5M, roughly 1.8× INDEPENDENT BANK CORP). INDEPENDENT BANK CORP runs the higher net margin — 35.5% vs 12.3%, a 23.2% gap on every dollar of revenue. On growth, INDEPENDENT BANK CORP posted the faster year-over-year revenue change (46.9% vs 22.1%). INDEPENDENT BANK CORP produced more free cash flow last quarter ($75.5M vs $68.0M). Over the past eight quarters, INDEPENDENT BANK CORP's revenue compounded faster (24.3% CAGR vs 17.6%).

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

INDB vs PEN — Head-to-Head

Bigger by revenue
PEN
PEN
1.8× larger
PEN
$385.4M
$212.5M
INDB
Growing faster (revenue YoY)
INDB
INDB
+24.7% gap
INDB
46.9%
22.1%
PEN
Higher net margin
INDB
INDB
23.2% more per $
INDB
35.5%
12.3%
PEN
More free cash flow
INDB
INDB
$7.5M more FCF
INDB
$75.5M
$68.0M
PEN
Faster 2-yr revenue CAGR
INDB
INDB
Annualised
INDB
24.3%
17.6%
PEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INDB
INDB
PEN
PEN
Revenue
$212.5M
$385.4M
Net Profit
$75.3M
$47.3M
Gross Margin
68.0%
Operating Margin
15.4%
Net Margin
35.5%
12.3%
Revenue YoY
46.9%
22.1%
Net Profit YoY
50.6%
40.6%
EPS (diluted)
$1.51
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDB
INDB
PEN
PEN
Q4 25
$212.5M
$385.4M
Q3 25
$203.3M
$354.7M
Q2 25
$147.5M
$339.5M
Q1 25
$145.5M
$324.1M
Q4 24
$144.7M
$315.5M
Q3 24
$141.7M
$301.0M
Q2 24
$137.9M
$299.4M
Q1 24
$137.4M
$278.7M
Net Profit
INDB
INDB
PEN
PEN
Q4 25
$75.3M
$47.3M
Q3 25
$34.3M
$45.9M
Q2 25
$51.1M
$45.3M
Q1 25
$44.4M
$39.2M
Q4 24
$50.0M
$33.7M
Q3 24
$42.9M
$29.5M
Q2 24
$51.3M
$-60.2M
Q1 24
$47.8M
$11.0M
Gross Margin
INDB
INDB
PEN
PEN
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Q1 24
65.0%
Operating Margin
INDB
INDB
PEN
PEN
Q4 25
15.4%
Q3 25
21.8%
13.8%
Q2 25
44.6%
12.0%
Q1 25
39.3%
12.4%
Q4 24
13.6%
Q3 24
39.0%
11.7%
Q2 24
48.1%
-27.0%
Q1 24
45.5%
4.3%
Net Margin
INDB
INDB
PEN
PEN
Q4 25
35.5%
12.3%
Q3 25
16.8%
12.9%
Q2 25
34.6%
13.3%
Q1 25
30.5%
12.1%
Q4 24
34.6%
10.7%
Q3 24
30.3%
9.8%
Q2 24
37.2%
-20.1%
Q1 24
34.8%
3.9%
EPS (diluted)
INDB
INDB
PEN
PEN
Q4 25
$1.51
$1.20
Q3 25
$0.69
$1.17
Q2 25
$1.20
$1.15
Q1 25
$1.04
$1.00
Q4 24
$1.18
$0.88
Q3 24
$1.01
$0.75
Q2 24
$1.21
$-1.55
Q1 24
$1.12
$0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDB
INDB
PEN
PEN
Cash + ST InvestmentsLiquidity on hand
$186.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.6B
$1.4B
Total Assets
$24.9B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDB
INDB
PEN
PEN
Q4 25
$186.9M
Q3 25
$321.0M
Q2 25
$421.8M
Q1 25
$376.1M
Q4 24
$324.4M
Q3 24
$280.5M
Q2 24
$288.3M
Q1 24
$223.1M
Stockholders' Equity
INDB
INDB
PEN
PEN
Q4 25
$3.6B
$1.4B
Q3 25
$3.5B
$1.4B
Q2 25
$3.1B
$1.3B
Q1 25
$3.0B
$1.2B
Q4 24
$3.0B
$1.2B
Q3 24
$3.0B
$1.1B
Q2 24
$2.9B
$1.2B
Q1 24
$2.9B
$1.2B
Total Assets
INDB
INDB
PEN
PEN
Q4 25
$24.9B
$1.8B
Q3 25
$25.0B
$1.7B
Q2 25
$20.0B
$1.7B
Q1 25
$19.9B
$1.6B
Q4 24
$19.4B
$1.5B
Q3 24
$19.4B
$1.5B
Q2 24
$19.4B
$1.5B
Q1 24
$19.3B
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDB
INDB
PEN
PEN
Operating Cash FlowLast quarter
$78.9M
$86.5M
Free Cash FlowOCF − Capex
$75.5M
$68.0M
FCF MarginFCF / Revenue
35.5%
17.7%
Capex IntensityCapex / Revenue
1.6%
4.8%
Cash ConversionOCF / Net Profit
1.05×
1.83×
TTM Free Cash FlowTrailing 4 quarters
$239.0M
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDB
INDB
PEN
PEN
Q4 25
$78.9M
$86.5M
Q3 25
$52.2M
$58.3M
Q2 25
$106.7M
$44.9M
Q1 25
$13.3M
$49.0M
Q4 24
$42.9M
$51.1M
Q3 24
$70.2M
$56.5M
Q2 24
$65.6M
$22.6M
Q1 24
$51.1M
$38.3M
Free Cash Flow
INDB
INDB
PEN
PEN
Q4 25
$75.5M
$68.0M
Q3 25
$49.7M
$42.0M
Q2 25
$102.5M
$29.4M
Q1 25
$11.3M
$35.5M
Q4 24
$36.5M
$45.7M
Q3 24
$64.4M
$51.0M
Q2 24
$61.9M
$18.1M
Q1 24
$46.7M
$32.5M
FCF Margin
INDB
INDB
PEN
PEN
Q4 25
35.5%
17.7%
Q3 25
24.4%
11.8%
Q2 25
69.5%
8.7%
Q1 25
7.8%
11.0%
Q4 24
25.2%
14.5%
Q3 24
45.4%
16.9%
Q2 24
44.9%
6.0%
Q1 24
34.0%
11.7%
Capex Intensity
INDB
INDB
PEN
PEN
Q4 25
1.6%
4.8%
Q3 25
1.2%
4.6%
Q2 25
2.9%
4.6%
Q1 25
1.4%
4.2%
Q4 24
4.4%
1.7%
Q3 24
4.1%
1.8%
Q2 24
2.7%
1.5%
Q1 24
3.2%
2.1%
Cash Conversion
INDB
INDB
PEN
PEN
Q4 25
1.05×
1.83×
Q3 25
1.52×
1.27×
Q2 25
2.09×
0.99×
Q1 25
0.30×
1.25×
Q4 24
0.86×
1.52×
Q3 24
1.64×
1.91×
Q2 24
1.28×
Q1 24
1.07×
3.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INDB
INDB

Segment breakdown not available.

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

Related Comparisons